Skip to main content
Log in

High serum adiponectin correlates with advanced liver disease in patients with chronic hepatitis B virus infection

  • Original Article
  • Published:
Hepatology International Aims and scope Submit manuscript

Abstract

Purpose

Adiponectin possesses anti-inflammatory and insulin-sensitizing properties. Little is known about the role of adiponectin in hepatitis B-related liver disease.

Methods

Serum adiponectin and hepatitis B viral factors were cross-sectionally assayed in 280 patients with chronic hepatitis B virus (HBV) infection including 120 patients with chronic HBV infection, 40 patients with cirrhosis, and 120 patients with hepatocellular carcinoma (HCC); 116 healthy adults were used as controls. The dynamics of serum adiponectin level was also studied longitudinally in 25 patients with hepatitis B e antigen (HBeAg) seroconversion (SC).

Results

We found that serum adiponectin level in patients with chronic HBV infection was similar to that in healthy controls and was significantly lower than patients with cirrhosis and HCC. In univariate analysis, high serum adiponectin level significantly correlated with the presence of HBV-related cirrhosis or HCC, abnormal serum ALT level, and HBV genotype C. Multivariate analysis revealed that high serum adiponectin level significantly correlated with the development of HCC. Serum adiponectin levels remained stationary in patients experiencing HBeAg SC.

Conclusions

Our findings suggest that HBV infection itself does not affect adiponectin levels. Serum adiponectin level correlates with the progression of HBV-related liver diseases but not with the development of HBeAg SC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Explore related subjects

Discover the latest articles and news from researchers in related subjects, suggested using machine learning.

References

  1. Kao JH, Chen DS. Global control of hepatitis B virus. Lancet Infect Dis 2002;2:395–403. doi:10.1016/S1473-3099(02)00315-8

    Article  PubMed  Google Scholar 

  2. Lee WM. Hepatitis B virus infection. N Engl J Med 1997;337:1733–1745. doi:10.1056/NEJM199712113372406

    Article  PubMed  CAS  Google Scholar 

  3. Liu CJ, Chen PJ, Lai MY, Kao JH, Chang CF, Wu HL, et al. A prospective study characterizing full-length hepatitis B virus genomes during acute exacerbation. Gastroenterology 2003;124:80–90. doi:10.1053/gast.2003.50003

    Article  PubMed  CAS  Google Scholar 

  4. Berg AH, Combs TP, Du X, Brownlee M, Scherer PE. The adipocyte-secreted protein ACRP30 enhances hepatic insulin action. Nat Med 2001;7:947–953. doi:10.1038/90992

    Article  PubMed  CAS  Google Scholar 

  5. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999;257:79–83. doi:10.1006/bbrc.1999.0255

    Article  PubMed  CAS  Google Scholar 

  6. Hu E, Liang P, Spiegelman BM. AdipoQ is a novel adipocyte-specific gene dysregulated in obesity. J Biol Chem 1996;271:10697–10703. doi:10.1074/jbc.271.18.10697

    Article  PubMed  CAS  Google Scholar 

  7. Hotta K, Funahashi T, Bodkin NL, Ortmeyer HK, Arita Y, Hansen BC, et al. Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes 2001;50:1126–1133. doi:10.2337/diabetes.50.5.1126

    Article  PubMed  CAS  Google Scholar 

  8. Bajaj M, Suraamornkul S, Piper P, Hardies LJ, Glass L, Cersosimo E, et al. Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients. J Clin Endocrinol Metab 2004;89:200–206. doi:10.1210/jc.2003-031315

    Article  PubMed  CAS  Google Scholar 

  9. Gil-Campos M, Canete R, Gil A. Adiponectin, the missing link in insulin resistance and obesity. Clin Nutr 2004;23:963–974. doi:10.1016/j.clnu.2004.04.010

    Article  PubMed  CAS  Google Scholar 

  10. Masaki T, Chiba S, Tatsukawa H, Yasuda T, Noguchi H, Seike M, et al. Adiponectin protects LPS-induced liver injury through modulation of TNF-alfa in KK-Ay-obese mice. Hepatology 2004;40:177–184. doi:10.1002/hep.20282

    Article  PubMed  CAS  Google Scholar 

  11. Kamada Y, Tamura S, Kiso S, Matsumoto H, Saji Y, Yoshida Y, et al. Enhanced carbon tetrachloride-induced liver fibrosis in mice lacking adiponectin. Gastroenterology 2003;125:1796–1807. doi:10.1053/j.gastro.2003.08.029

    Article  PubMed  CAS  Google Scholar 

  12. Custro N, Carroccio A, Ganci A, Scafidi V, Campagna P, Di Prima L, et al. Glycemic homeostasis in chronic viral hepatitis and liver cirrhosis. Diabetes Metab 2001;27:476–481

    PubMed  CAS  Google Scholar 

  13. Hui JM, Sud A, Farrell GC, Bandara P, Byth K, Kench JG, et al. Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression. Gastroenterology 2003;125:1695–1704. doi:10.1053/j.gastro.2003.08.032

    Article  PubMed  CAS  Google Scholar 

  14. Jonsson JR, Moschen AR, Hickman IJ, Richardson MM, Kaser S, Clouston AD, et al. Adiponectin and its receptors in patients with chronic hepatitis C. J Hepatol 2005;43:929–936. doi:10.1016/j.jhep.2005.05.030

    Article  PubMed  CAS  Google Scholar 

  15. Kaser S, Moschen A, Cayon A, Kaser A, Crespo J, Pons-Romero F, et al. Adiponectin and its receptors in non-alcoholic steatohepatitis. Gut 2005;54:117–121. doi:10.1136/gut.2003.037010

    Article  PubMed  CAS  Google Scholar 

  16. Liu CJ, Chen PJ, Jeng YM, Huang WL, Yang WS, Lai MY, et al. Serum adiponectin correlates with viral characteristics but not histologic features in patients with chronic hepatitis C. J Hepatol 2005;43:235–242. doi:10.1016/j.jhep.2005.02.044

    Article  PubMed  CAS  Google Scholar 

  17. Neumeier M, Hellerbrand C, Gäbele E, Buettner R, Bollheimer C, Weigert J, et al. Adiponectin and its receptors in rodent models of fatty liver disease and liver cirrhosis. World J Gastroenterol 2006;12:5490–5494

    PubMed  CAS  Google Scholar 

  18. Petit JM, Minello A, Jooste V, Bour JB, Galland F, Duvillard L, et al. Decreased plasma adiponectin concentrations are closely related to steatosis in hepatitis C virus infected patients. J Clin Endocrinol Metab 2005;90:2240–2243. doi:10.1210/jc.2004-1266

    Article  PubMed  CAS  Google Scholar 

  19. Siagris D, Vafiadis G, Michalaki M, Lekkou A, Starakis I, Makri M, et al. Serum adiponectin in chronic hepatitis C and B. J Viral Hepat 2007;14:577–583. doi:10.1111/j.1365-2893.2007.00850.x

    Article  PubMed  CAS  Google Scholar 

  20. Tietge UJ, Boker KH, Manns MP, Bahr MJ. Elevated circulating adiponectin levels in liver cirrhosis are associated with reduced liver function and altered hepatic hemodynamics. Am J Physiol Endocrinol Metab 2004;287:E82–E92. doi:10.1152/ajpendo.00494.2003

    Article  PubMed  CAS  Google Scholar 

  21. Wang AY, Hickman IJ, Richards AA, Whitehead JP, Prins JB, Macdonald GA. High molecular weight adiponectin correlates with insulin sensitivity in patients with hepatitis C genotype 3 but not genotype 1 infection. Am J Gastroenterol 2005;100:2717–2723. doi:10.1111/j.1572-0241.2005.00311.x

    Article  PubMed  CAS  Google Scholar 

  22. Xu A, Wang Y, Keshaw H, Xu LY, Lam KS, Cooper GJ. The fat-derived hormone adiponectin alleviates alcoholic and non-alcoholic fatty liver diseases in mice. J Clin Invest 2003;112:91–100

    PubMed  CAS  Google Scholar 

  23. Yokoyama H, Hirose H, Ohgo H, Saito I. Inverse association between serum adiponectin level and transaminase activities in Japanese male workers. J Hepatol 2004;41:19–24. doi:10.1016/j.jhep.2004.03.003

    Article  PubMed  CAS  Google Scholar 

  24. Targher G, Bertolini L, Rodella S, Zoppini G, Scala L, Zenari L, et al. Associations between plasma adiponectin concentrations and liver histology in patients with non-alcoholic fatty liver disease. Clin Endocrinol (Oxf) 2006;64:679–683. doi:10.1111/j.1365-2265.2006.02527.x

    Article  CAS  Google Scholar 

  25. Pagano C, Soardo G, Esposito W, Fallo F, Basan L, Donnini D, et al. Plasma adiponectin is decreased in non-alcoholic fatty liver disease. Eur J Endocrinol 2005;152:113–118. doi:10.1530/eje.1.01821

    Article  PubMed  CAS  Google Scholar 

  26. Musso G, Gambino R, Durazzo M, Biroli G, Carello M, Fagà E, et al. Adipokines in NASH: postprandial lipid metabolism as a link between adiponectin and liver disease. Hepatology 2005;42:1175–1183. doi:10.1002/hep.20896

    Article  PubMed  CAS  Google Scholar 

  27. Musso G, Gambino R, Biroli G, Carello M, Fagà E, Pacini G, et al. Hypoadiponectinemia predicts the severity of hepatic fibrosis and pancreatic beta-cell dysfunction in nondiabetic nonobese patients with nonalcoholic steatohepatitis. Am J Gastroenterol 2005;100:2438–2446. doi:10.1111/j.1572-0241.2005.00297.x

    Article  PubMed  CAS  Google Scholar 

  28. Hui CK, Zhang HY, Lee NP, Chan W, Yueng YH, Leung KW, et al. Serum adiponectin is increased in advancing liver fibrosis and declines with reduction in fibrosis in chronic hepatitis B. J Hepatol 2007;47:191–202. doi:10.1016/j.jhep.2007.02.023

    Article  PubMed  CAS  Google Scholar 

  29. Kaser S, Moschen A, Kaser A, Ludwiczek O, Ebenbichler CF, Vogel W, et al. Circulating adiponectin reflects severity of liver disease but not insulin sensitivity in liver cirrhosis. J Intern Med 2005;258:274–280. doi:10.1111/j.1365-2796.2005.01543.x

    Article  PubMed  CAS  Google Scholar 

  30. Tacke F, Wüstefeld T, Horn R, Luedde T, Srinivas Rao A, Manns MP, et al. High adiponectin in chronic liver disease and cholestasis suggests biliary route of adiponectin excretion in vivo. J Hepatol 2005;42:666–673. doi:10.1016/j.jhep.2004.12.024

    Article  PubMed  CAS  Google Scholar 

  31. Lu JY, Chuang LM, Yang WS, Tai TY, Lai MY, Chen PJ, et al. Adiponectin levels among patients with chronic hepatitis B and C infections and in response to IFN-alpha therapy. Liver Int 2005;25:752–759. doi:10.1111/j.1478-3231.2005.1007.x

    Article  PubMed  CAS  Google Scholar 

  32. Hsu YS, Chien RN, Yeh CT, Sheen IS, Chiou HY, Chu CM, et al. Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B. Hepatology 2002;35:1522–1527. doi:10.1053/jhep.2002.33638

    Article  PubMed  Google Scholar 

  33. Yeh SH, Tsai CY, Kao JH, Liu CJ, Kuo TJ, Lin MW, et al. Combined real-time PCR quantification and signature single nucleotide polymorphism genotyping of hepatitis B virus in one-tube reaction. J Hepatol 2004;41:659–666. doi:10.1016/j.jhep.2004.06.031

    Article  PubMed  CAS  Google Scholar 

  34. Tilg H, Wilmer A, Vogel W, Herold M, Nölchen B, Judmaier G, et al. Serum levels of cytokines in chronic liver diseases. Gastroenterology 1992;103:264–274

    PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The study was supported by grants from the National Taiwan University Hospital; the National Taiwan University; the National Science Council (NSC 95-2314-B-002-094), Department of Health, Executive Yuan, Taiwan; National Health Research Institutes (NHRI-EX93-CD9201 and NHRI-EX94-CD9201), Taiwan; and Liver Disease Prevention and Treatment Research Foundation, Taiwan.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jia-Horng Kao.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Liu, CJ., Chen, PJ., Lai, MY. et al. High serum adiponectin correlates with advanced liver disease in patients with chronic hepatitis B virus infection. Hepatol Int 3, 364–370 (2009). https://doi.org/10.1007/s12072-008-9111-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12072-008-9111-0

Keywords

Profiles

  1. Chen-Hua Liu